FDA approves new treatment for erosive esophagitis

FDA approves new treatment for erosive esophagitis

The U.S. Food and Drug Administration (FDA) has approved vonoprazan tablets 10 mg and 20 mg (Voquezna, Phathom Pharmaceuticals) for the cure and maintenance of healing of all grades of erosive esophagitis, also known as erosive gastroesophageal reflux disease (GERD), as well as relief from associated heartburn, the company announced. Vonoprazan, an oral potassium-competitive acid …

Read more

British Columbia psychiatrist resigns license after patient complains of abuse during psychedelic therapy study | News from Radio-Canada

British Columbia psychiatrist resigns license after patient complains of abuse during psychedelic therapy study |  News from Radio-Canada

A British Columbia psychiatrist has permanently surrendered her medical license in response to a complaint about her treatment of a PTSD patient participating in a clinical trial of MDMA-assisted psychotherapy, CBC News has learned. Donna Dryer of Cortes Island irrevocably resigned her registration on Aug. 1 and received a formal reprimand after admitting to unprofessional …

Read more

FDA warns that much of ‘ketamine therapy’ appears to be just a party

FDA warns that much of 'ketamine therapy' appears to be just a party

Image of Julia Christe/Getty Images Shocking news: All that “ketamine therapy” your friend has been doing might actually just be a party, really. Ketamine, a dissociative anesthetic known for its psychedelic effects, has had a big year. Thanks in large part to its famous fans, a list that includes SpaceX honcho Elon Musk, the number …

Read more